[ad_1]
Pfizer said the final phase test of the corona vaccine by US pharmaceutical company Pfizer and its German partner Bioentech was completed 95 percent effective.
Reuters quoted the agency as saying Wednesday that it would soon apply for approval for its emergency use in the United States and that Pfizer had the necessary two months of safety information to use the vaccine.
According to Pfizer, the effectiveness of this vaccine does not vary by age, race, or color. Also, there are no major side effects from using the vaccine. Because of this, the vaccine can be applied anywhere in the world, the organization said.
The vaccine is more than 94 percent effective for people 65 and older, especially those at high risk for coronavirus, Pfizer said.
Early last week, the company analyzed preliminary results of the trial and said the vaccine was 90 percent effective. Another American company, Moderna, also released preliminary data Monday showing the effectiveness of its vaccine at about 95 percent (94.5%).
Pfizer said today that only 160 people have been affected by the trial of 43,000 volunteers. Of these, 162 have received placebo and eight have been vaccinated.
Ten of the volunteers were seriously affected by the crown. One of them has been vaccinated.
